Skip to content
Screener

GeneDx Holdings WGS Total Current Assets

Total Current Assets at other companies

Natera, Inc. logo
Natera, Inc.NTRA
$1.66B+15.9%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
$479.04M+14.9%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
$1.29B+100%
Personalis, Inc. logo
Personalis, Inc.PSNL
$258.2M+25.1%
NeoGenomics logo
NeoGenomicsNEO
$381.48M-2.8%
Quest Diagnostics logo
Quest DiagnosticsDGX
$2.84B+29.4%

Other financials

Income statement

See full
Revenue$102.3M+17.4%
Gross profit$68.2M+16.6%
Operating income-$57.5M-1,163%
Net income-$63.3M-870%
EPS (diluted)-$2.16-839%

Balance sheet

See full
Cash & equivalents$94.9M-5.7%
Total debt$96.7M+82.5%
Total equity$254.1M-1.3%
Total assets$506.3M+13.4%

Cash flow

See full
Operating cash flow-$32.4M-418%
CapEx$6.5M+5.3%
Free cash flow-$38.9M-1,059%

Valuation

See full
Market cap$2.08B-31.7%
Enterprise value$2.08B-31.2%
P/S4.7×-3.7×

Profitability

See full
Gross margin69.6%+4.3pp
Operating margin-14.9%
Net margin-17.6%
FCF margin3.8%+2.1pp

Returns & leverage

See full
Return on equity-30.4%
Debt / equity0.4×+0.2×
Current ratio3.1×-0.2×

Where this comes from

Reported directly by GeneDx Holdings in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The source filing: GeneDx Holdings’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001818331-26-000041
Line itemMarch 31, 2026 (Unaudited)December 31, 2025
Accounts receivable76,92974,370
Inventory, net12,24113,951
Prepaid expenses and other current assets10,7748,685
Total current assets270,629268,288
Operating lease right-of-use assets34,65323,412
Property and equipment, net50,12545,693
Goodwill1,64113,520
Intangible assets, net144,969168,481

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is GeneDx Holdings's total current assets?
GeneDx Holdings (WGS) reported total current assets of $270.63M in Q1 2026.
How has GeneDx Holdings's total current assets changed year-over-year?
GeneDx Holdings's total current assets increased by 19.8% year-over-year, from $225.82M to $270.63M.
What is the long-term trend for GeneDx Holdings's total current assets?
Over 5 years (2020 to 2025), GeneDx Holdings's total current assets has grown at a 9.0% compound annual growth rate (CAGR), from $174.11M to $268.29M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.

Ask your AI about GeneDx Holdings's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude